| Members |
targetComponentId |
| Acute myelofibrosis |
Acute megakaryoblastic leukemia |
| Acute myelofibrosis |
Myelodysplastic neoplasm with biallelic TP53 inactivation |
| Acute myelofibrosis |
Primary myelofibrosis |
| Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust] |
Allergy to animal protein |
| Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust] |
Allergy to house dust (finding) |
| Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust] |
Allergic rhinitis caused by pollen |
| Animal protein and epidermal substance |
Animal material |
| Animal protein and epidermal substance |
Animal protein |
| Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer allowable value |
| Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer cM1 (qualifier value) |
| Bilateral transcricoid bronchography |
Fluoroscopy of bilateral bronchi with contrast |
| Bilateral transcricoid bronchography |
CT of bilateral bronchi with contrast |
| Bilateral transglottic bronchography |
Fluoroscopy of bilateral bronchi with contrast |
| Bilateral transglottic bronchography |
CT of bilateral bronchi with contrast |
| Blind hypotensive eye |
Phthisis bulbi |
| Blind hypotensive eye |
Atrophy of globe of eye |
| Compression sclerosis |
Injection of sclerosing agent in varicose vein |
| Compression sclerosis |
Microsclerotherapy to spider veins of leg |
| Congenital articular rigidity with myopathy |
Congenital anomaly of skeletal muscle |
| Congenital articular rigidity with myopathy |
Arthrogryposis |
| Conventional release suspension for infusion and/or injection |
Dispersion for infusion |
| Conventional release suspension for infusion and/or injection |
Suspension for injection |
| Duodenum double contrast exam. |
CT of duodenum |
| Duodenum double contrast exam. |
Magnetic resonance imaging of duodenum (procedure) |
| Duodenum double contrast exam. |
Fluoroscopic duodenography (procedure) |
| Duodenum double contrast exam. |
Computed tomography of duodenum with contrast (procedure) |
| Dupuytren-contractuur |
Contracture |
| Dupuytren-contractuur |
Focal fibromatosis |
| Dupuytren-contractuur |
Fibrous bands |
| Ehlers-Danlos-syndroom zonder hydroxylysinedeficiëntie van oculair type |
Ehlers-Danlos syndrome musculocontractural type (disorder) |
| Ehlers-Danlos-syndroom zonder hydroxylysinedeficiëntie van oculair type |
Brittle cornea syndrome (disorder) |
| Entire middle cells of ethmoid sinus |
Entire anterior cells of ethmoid sinus |
| Entire middle cells of ethmoid sinus |
Entire posterior cells of ethmoid sinus |
| Fetus or neonate affected by ectopic pregnancy NOS |
Ectopic pregnancy |
| Fetus or neonate affected by ectopic pregnancy NOS |
Combined pregnancy |
| Fetus or neonate affected by unspecified ectopic pregnancy |
Ectopic pregnancy |
| Fetus or neonate affected by unspecified ectopic pregnancy |
Combined pregnancy |
| Handicapped aids (& for severely handicapped) |
Provision of aid for disability (procedure) |
| Handicapped aids (& for severely handicapped) |
Provision of aid for severe disability |
| Handicapped: [relative - physically] or [spouse] or [child] |
Child of subject has disability (situation) |
| Handicapped: [relative - physically] or [spouse] or [child] |
Spouse has disability (situation) |
| Handicapped: [relative - physically] or [spouse] or [child] |
Family history of disability |
| Isotope static placentography |
Ultrasonography of placenta (procedure) |
| Isotope static placentography |
Ultrasound obstetric doppler (procedure) |
| Isotope static placentography |
MRI of placenta |
| Lansoprazole 15mg m/r capsule/naproxen 250mg tablet |
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
| Lansoprazole 15mg m/r capsule/naproxen 250mg tablet |
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Lansoprazole 15mg m/r capsule/naproxen 375mg tablet |
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) |
| Lansoprazole 15mg m/r capsule/naproxen 375mg tablet |
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
| Lansoprazole 15mg m/r capsule/naproxen 500mg tablet |
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
| Lansoprazole 15mg m/r capsule/naproxen 500mg tablet |
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Large visual image |
Macropsia (disorder) |
| Large visual image |
Dissociative neurological symptom disorder with visual symptom (disorder) |
| Metastases by primary malignancy |
Primary malignant neoplasm (disorder) |
| Metastases by primary malignancy |
Metastatic malignant neoplasm (disorder) |
| Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
| Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug) |
| Placental vasography |
Ultrasound obstetric doppler (procedure) |
| Placental vasography |
Ultrasonography of placenta (procedure) |
| Placental vasography |
MRI of placenta |
| Placentography (& contrast) |
MRI of placenta |
| Placentography (& contrast) |
Plain X-ray of placenta |
| Placentography (& contrast) |
Ultrasonography of placenta (procedure) |
| Placentography (& contrast) |
MRI of placenta |
| Placentography (& contrast) |
Ultrasonography of placenta (procedure) |
| Placentography (& contrast) |
Plain X-ray of placenta |
| Placentography |
Ultrasonography of placenta (procedure) |
| Placentography |
MRI of placenta |
| Placentography |
Plain X-ray of placenta |
| Placentography requested |
US obstetric scan requested |
| Placentography requested |
Ultrasonography of placenta requested |
| Psychologic test, organic battery |
Neuropsychological testing |
| Psychologic test, organic battery |
Assessment using repeatable battery for the assessment of neuropsychological status (procedure) |
| Small visual image |
Micropsia (disorder) |
| Small visual image |
Dissociative neurological symptom disorder with visual symptom (disorder) |
| Structure of middle cells of ethmoid sinus |
Structure of posterior cells of ethmoid sinus |
| Structure of middle cells of ethmoid sinus |
Structure of anterior cells of ethmoid sinus |
| T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis |
American Joint Committee on Cancer cT3 (qualifier value) |
| T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis |
cN1 |
| T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis |
cN1 |
| T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis |
American Joint Committee on Cancer cT3 (qualifier value) |
| T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria |
American Joint Committee on Cancer cT3a (qualifier value) |
| T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria |
cT3b |
| T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria |
American Joint Committee on Cancer cT3c (qualifier value) |
| T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria |
American Joint Committee on Cancer cT3d (qualifier value) |
| Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor |
cTis(Paget) |
| Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor |
cTis(DCIS) |
| Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor |
cTis |
| [M]Acute panmyelosis |
Primary myelofibrosis |
| [M]Acute panmyelosis |
Myelodysplastic neoplasm with biallelic TP53 inactivation |
| [M]Acute panmyelosis |
Acute megakaryoblastic leukemia |
| amniografie |
Ultrasound scan - obstetric |
| amniografie |
Diagnostic ultrasound of gravid uterus |
| amniografie met contrast |
Diagnostic ultrasound of gravid uterus |
| amniografie met contrast |
Ultrasound scan - obstetric |
| angiocardiografie door seriële opnames in enkel vlak (verrichting) |
Cardiac MRI |
| angiocardiografie door seriële opnames in enkel vlak (verrichting) |
Contrast echocardiography (procedure) |
| angiocardiografie door seriële opnames in enkel vlak (verrichting) |
Echocardiography |
| angiocardiografie door seriële opnames in enkel vlak (verrichting) |
Magnetic resonance imaging of heart with contrast (procedure) |
| angiocardiografie door seriële opnames in enkel vlak (verrichting) |
Fluoroscopic angiography of heart with contrast (procedure) |
FHIR